Intratumoral hypoxia and mechanisms of immune evasion mediated by hypoxia- inducible factors

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Activation of the innate and adaptive immune systems represents a promising strategy for defeating cancer. However, during tumor progression, cancer cells battle to shift the balance from immune activation to immunosuppression. Critical sites of this battle are regions of intratumoral hypoxia, and a major driving force for immunosuppression is the activity of hypoxia-inducible factors, which regulate the transcription of large batteries of genes in both cancer and stromal cells that block the infiltration and activity of cytotoxic T lymphocytes and natural killer cells, while stimulating the infiltration and activity of regulatory T cells, myeloid-derived suppressor cells, and tumor-associated macrophages. Targeting hypoxia-inducible factors or their target gene products may restore anticancer immunity and improve the response to immunotherapies.

Original languageEnglish (US)
Pages (from-to)73-83
Number of pages11
JournalPhysiology
Volume36
Issue number2
DOIs
StatePublished - 2021

Keywords

  • CTLA4
  • HIF-1α
  • HIF-2α
  • Oxygen
  • PD1
  • PDL1

ASJC Scopus subject areas

  • Physiology

Fingerprint

Dive into the research topics of 'Intratumoral hypoxia and mechanisms of immune evasion mediated by hypoxia- inducible factors'. Together they form a unique fingerprint.

Cite this